TBS Dental Introduces Revolutionary rezSHARP Hygiene Instrument Line
Resiliently Sharp Line of Scalers and Curettes
rezSHARP Launch Photo rezSHARP line of Scalers and Curettes by TBS Dental
…
‘Customer Transformation’ by Ex-Googler Chris Hood to Hit Shelves on Aug. 1, 2023
With a Focus on Empathy, Innovation, AI, and Customer Value, the Book Serves as a Comprehensive Guide for Businesses Navigating Today’s Dynamic Digital Environment and Aligning With Their Customers’ Ever-Evolving Needs and Aspirations
‘Customer Transformation’ Cover
Cover for the book ‘Customer Transformation by Chris Hood’
RANCHO SANTA MARGARITA, Calif., July 26, 2023 (Newswire.com)
–
CH Publishing is thrilled to announce the release of Chris Hood’s groundbreaking new book “Customer Transformation.” This game-changing business strategy guide seeks to enlighten companies on transforming their processes, culture, and technologies to align seamlessly with their customers’ evolving needs and aspirations. The much-anticipated work is set to hit bookstores and online platforms on Aug. 1, 2023.
Chris Hood, a digital strategy and innovation expert who has worked at industry-leading companies such as Google, Fox, and Disney, shares his knowledge and innovative insights through this essential guide. “Customer Transformation” offers a unique blend of compelling narratives, real-world case studies from industry powerhouses like Disney, Zebra Technologies, Uber, Bank of America, Shark Tank, Anheuser-Busch, ING Bank, Lego, and more, along with actionable guidelines. The book provides more than a strategy; it is a comprehensive blueprint for businesses seeking to navigate today’s complex digital landscape, nurturing dynamic and enduring customer relationships.
“Customer Transformation demystifies the critical components for leveraging empathy, innovation, and digital acceleration, the cornerstones of today’s most prosperous businesses,” Hood asserts. He also emphasizes the importance of infusing an emotional layer into any digital strategy to enhance consumer engagement and loyalty.
The book is organized into seven stages that offer a wealth of insights into how organizations can leverage technology to interface with people, cultivate a customer-centric culture that drives innovation, and understand how to align with customers’ expectations and values.
Key takeaways from the book include:
- Understanding your customers’ needs before implementing any strategy
- The vital importance of experimenting, innovating, and taking an outside-in perspective
- The role of technology and AI in shaping customer interactions and business strategies
- Connecting every technology decision back to customer value propositions.
Hood’s “Customer Transformation” is a survival guide for businesses in the digital era. It aims to equip readers with the tools to pivot, adapt, and, most importantly, align customers at the heart of every decision, thus fostering sustainable growth and shaping organizations that meet and exceed customer expectations.
The book will be available on Amazon, Barnes & Noble, and directly on ChrisHood.com. For more information on Chris Hood and his work, visit his author website at chrishood.com or the book’s website at customertransformation.com.
For press inquiries or further information, please contact CH Publishing at 657-222-4747 or [email protected].
About the Author:
CHRIS HOOD is a digital strategist, public speaker, podcast host, and innovator focused on building customer-centric cultures and development. Today, he advises companies on Customer Transformation, hosts his weekly Digital Show, and teaches business and technology at Southern New Hampshire University.
Contact Information:
Jill Colwell
Publicist
657-222-4747
Chris Hood
Author
657-222-4747
Original Source:
‘Customer Transformation’ by Ex-Googler Chris Hood to Hit Shelves on Aug. 1, 2023
The post ‘Customer Transformation’ by Ex-Googler Chris Hood to Hit Shelves on Aug. 1, 2023 first appeared on RSVTV news.
HealthJoy Leader Wins Teladoc Health Forum Transformational Leadership Award
Doug Morse-Schindler of HealthJoy Honored for Driving the Adoption of Virtual Care through Bold Leadership and an Unwavering Commitment to Excellence
…
Sendero Managing Director Jeff Schar Elected to the Tennessee Chapter of HIMSS Board of Directors
Sendero Managing Director Jeff Schar
DALLAS, July 26, 2023 (Newswire.com)
–
Sendero, a management consulting firm with expertise delivering strategic p…
Imagene’s AI-Based Molecular Profiling Revolutionizes Lung Cancer Diagnostics: Two Patients Receive Immediate Targeted Therapy, Avert Brain Radiation
A groundbreaking case report publication on the impact of rapid molecular testing on lung cancer patients
Schematic representation of the case
The adoption of new tools as AI-based molecular profiling in the clinical workflow has the potential to dramatically improve the routine pipeline and enhance the abilities of physicians to provide optimal patient care
TEL AVIV, Israel, July 26, 2023 (Newswire.com)
–
Imagene, an emerging leader in AI-based precision oncology, is pleased to announce the publication of a case report in the Journal of Clinical Pathology. The report, titled “Artificial Intelligence (AI) Molecular Analysis Tool Assists in Rapid Treatment Decision in Lung Cancer” demonstrates the successful application of Imagene’s AI technology in rapid molecular testing for lung cancer patients, conducted as part of a joint prospective study with the Pathology Department at the Sourasky Medical Center.
The case report describes two patients in their early 40s who were admitted at the emergency room with severe headaches. Brain MRIs and CT scans revealed suspected metastatic lung cancer that was confirmed by a biopsy analysis at the pathology lab. The patients needed immediate intervention and could not afford to wait for comprehensive genomic profiling results. To allow prompt decisions without compromising the small amount of remaining tissue, Imagene’s rapid AI-based molecular testing was used as part of collaborative research.
Prof. Dov Hershkovitz, Head of the Pathology Department at the Sourasky Medical Center, said, “The ability to use Imagene’s AI technology in these cases was a game-changer. It allowed us to bypass the usual lengthy waiting period associated with comprehensive genomic profiling. This technology is revolutionizing the way we diagnose patients, with the potential to improve outcomes and save lives.”
The Imagene algorithmic inference identified, within minutes, positive EGFR mutation, from the biopsy H&E image. A subsequent rapid RT-PCR test for EGFR mutations was indeed positive, allowing for immediate targeted treatment initiation and avoiding the need for whole brain radiation therapy. Both patients’ MRI scans after two months showed significant improvement with disappearance of the enhancement. A news channel also featured this case, including an interview with the patient. She shared her personal experience and highlighted the significant positive psychological impact that the rapid testing had on her.
“These real-life cases underscore the transformative potential of AI in precision oncology,” said Dean Bitan, Co-founder and CEO of Imagene. “Our technology enabled the medical team to make a rapid, informed treatment decision, ultimately saving precious time and improving the patient’s prognosis. We are proud to be at the forefront of this revolution, working hand-in-hand with leading medical centers on prospective studies to enhance patient care and impact patients’ lives.”
“One of the hardest things as an oncologist is to tell my patients we need to wait for a molecular diagnosis in order to start the optimal personalized treatment. It is groundbreaking to be able to have a molecular profile from the biopsy image within minutes,” added Prof. Ido Wolf, Head of Oncology, Sourasky Medical Center. “With the help of the rapid AI-based diagnoses, we are able to navigate patients’ journeys and make immediate informed treatment decisions that have such a great impact on our patients’ lives.”
Imagene continues to pursue the advancement of AI in precision oncology, providing innovative solutions that enhance cancer patients’ care and streamline clinical workflows. This technology can make molecular testing accessible to all cancer patients, particularly those in under-tested populations.
About Imagene
Imagene is an emerging leader in AI-based precision oncology. The company leverages AI to profile, within minutes, a broad range of cancer biomarkers from a digitized biopsy image alone, providing physicians with immediate oncology intelligence to ensure optimal treatment for all cancer patients. Imagene’s multidisciplinary team of data scientists, biologists, software engineers, and medical experts is committed to scientific excellence and collaboration, advancing precision oncology, and improving patient outcomes.
For more information, please visit imagene-ai.com.
Contact Information:
Avital Rabani
Head of Marketing
Original Source:
Imagene’s AI-Based Molecular Profiling Revolutionizes Lung Cancer Diagnostics: Two Patients Receive Immediate Targeted Therapy, Avert Brain Radiation
3,000 Wild Donkeys Headed to the Peaceful Valley Donkey Rescue
Peaceful Valley has committed to taking 3,000 donkeys from the Bureau of Land Management
Saline Valley Wild Donkeys in Saline Valley Death Valley…
The post 3,000 Wild Donkeys Headed to the Peaceful Valley Donkey Rescue first appeared on RSVTV news.